Investor Relations

Latest Financial Results

FY 2020

Fiscal Year Ended Dec 31, 2020

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020


Company Overview

FSD is a specialty, biotech pharmaceutical R&D company that aims to deliver growth and returns to shareholders through the development over time of multiple applications of the company’s lead compound FSD201, ultra-micronized PEA.

Investor Contact Information

Company

FSD Pharma Inc.
199 Bay St.
Suite 4000
Toronto, ON M5L 1A9
Canada

Investor Relations

FSDPharma@KCSA.com

Transfer Agent

Computershare Trust Corporation
https://www.computershare.com/us